Free shipping on all orders over $ 500

Wilfortrine

Cat. No. M6227
Wilfortrine Structure
Size Price Availability Quantity
5mg USD 1100 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

Wilfortrine has several pharmacological effects, including an inhibitory effect on liver cancer cell proliferation. However, whether wilfortrine can induce liver cancer cell apoptosis has not been elucidated. We investigated the role of wilfortrine on liver cancer cell HepG2 apoptosis and analyzed its possible mechanisms to provide a theoretical basis for clinical analysis of liver cancer pathogenesis. Wilfortrine can induce liver cancer cell HepG2 apoptosis, but with no effect on the cell cycle, mainly by promoting Bax expression and inhibiting anti-apoptotic protein Bcl-2 expression.

Protocol
Cell Experiment
Cell lines HepG2 cells
Preparation method The HepG2 liver cancer cell line was maintained in DMEM supplemented with 10% FBS and 100 U/mL penicillin-streptomycin in a humid atmosphere containing 5% CO2 at 37°C. Wilfortrine (40 mM) was used to treat HepG2 liver cancer cells for 48 h.
Concentrations 40 mM
Incubation time 48 h
Animal Experiment
Animal models
Formulation
Dosages
Administration
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 873.81
Formula C41H47NO20
CAS Number 37239-48-8
Purity >98%
Solubility 10 mM in DMSO
Storage at -20°C
References

Effect of Combined Treatment Using Wilfortrine and Paclitaxel in Liver Cancer and Related Mechanism.
Li S, et al. Med Sci Monit. 2016 Apr 4;22:1109-14. PMID: 27043783.

Effect of wilfortrine on human hepatic cancer HepG2 cell proliferation potential in vitro.
Yue M, et al. Genet Mol Res. 2015 Nov 30;14(4):15349-55. PMID: 26634500.

Related Products
LY2334737

LY2334737 is an orally available valproic acid ester of gemcitabine, a broad-spectrum antimetabolite with antineoplastic activity.

TUG-891

TUG-891 is a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120).

GSK2981278

GSK2981278 is a highly potent and selective inverse agonist of retinoic acid receptor-related orphan receptor gamma (ROR gamma).

EXP-3174

EXP-3174 is a potent AT1 antagonist with Kis of 0.57 and 0.67 nM for rat and human forms, respectively.

NAV-2729

NAV-2729 is a selective ARF6 inhibitor with IC50 value of 1.0 μM.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: Wilfortrine supplier, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.